BIOCRYST PHARMACEUTICALS, INC. Inventory, Work in Process, Gross
BIOCRYST PHARMACEUTICALS, INC. (BCRX) had Inventory, Work in Process, Gross of $25.27 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryWorkInProcess · last filed 2026-08-05
- 2026-06-30: Inventory, Work in Process, Gross $25.27M.
- 2026-03-31: Inventory, Work in Process, Gross $20.54M.
- 2025-12-31: Inventory, Work in Process, Gross $12.89M.
- 2025-09-30: Inventory, Work in Process, Gross $14.98M.
| Period end | Inventory, Work in Process, Gross |
|---|---|
| 2026-06-30 | $25.27M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $20.54M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $12.89M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $14.98M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $15.94M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $17.43M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $16.15M 10-K · filed 2026-02-26 |
| 2024-09-30 | $15.76M 10-Q · filed 2024-11-05 |
| 2024-06-30 | $14.48M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $16.86M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $17.59M 10-K · filed 2025-02-25 |
| 2023-09-30 | $17.74M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $14.51M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $15.61M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $14.99M 10-K · filed 2024-02-27 |
| 2022-09-30 | $15.36M 10-Q · filed 2022-11-04 |
| 2022-06-30 | $15.62M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $10.43M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $9.67M 10-K · filed 2023-02-27 |
| 2021-09-30 | $6.62M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $4.60M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $5.01M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $2.56M 10-K · filed 2022-02-28 |
| 2014-12-31 | $267.00K 10-K · filed 2015-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |